BioCryst Pharmaceuticals Quarterly Balance Sheets Chart
Quarterly
|
Annual
BioCryst Pharmaceuticals Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 88,033,000 | 105,190,000 | 104,713,000 | 96,841,000 | 78,410,000 | 84,333,000 | 110,643,000 | 150,905,000 | 146,215,000 | 155,136,000 | 304,767,000 | 246,899,000 | 272,571,000 | 395,504,000 | 504,389,000 | 199,597,000 | 210,314,000 | 226,902,000 | 272,127,000 | 96,492,000 | 173,468,000 | 101,873,000 | 114,172,000 | 29,903,000 | 30,760,000 | 34,804,000 | 26,731,000 | 52,584,000 | 27,104,000 | 43,767,000 | 50,282,000 | 117,776,000 | 39,696,000 | 75,158,000 | 22,104,000 | 35,387,000 | 8,661,000 | 12,902,000 | 28,899,000 | 46,627,000 | 76,781,000 | 48,367,000 | 54,540,000 | 121,157,000 | 121,519,000 | 13,584,000 | 21,164,000 | 26,050,000 | 19,767,000 | 14,805,000 | 20,891,000 | 23,959,000 | 21,924,000 | 27,661,000 | 16,444,000 | 22,441,000 | 17,008,000 | 31,342,000 | 13,622,370 | 11,174,000 | 14,021,000 | 19,876,000 | 41,124,937 | 18,226,000 | 13,810,000 | 16,305,000 | 22,342,058 | 15,952,000 | 25,141,000 | 27,875,000 | 31,155,320 | 44,092,000 | 7,178,000 | 9,207,000 | 4,417,528 | 7,733,000 | 25,055,000 | 43,015,000 | 29,156,827 | 9,097,000 | 9,240,000 | 22,049,000 | 8,838,464 | 13,809,000 | 17,046,000 |
| restricted cash | 492,000 | 291,000 | 210,000 | 813,000 | 1,795,000 | 1,798,000 | 1,804,000 | 1,584,000 | 1,574,000 | 1,463,000 | 1,472,000 | 1,444,000 | 1,448,000 | 3,354,000 | 3,345,000 | 4,296,000 | 4,348,000 | 4,008,000 | 2,221,000 | 2,213,000 | 2,188,000 | 1,559,000 | 1,551,000 | 1,547,000 | 4,629,000 | 2,394,000 | 1,544,000 | 1,506,000 | 7,625,000 | 4,599,000 | 3,286,000 | 3,122,000 | 5,357,000 | 2,798,000 | 1,546,000 | 1,506,000 | 4,426,000 | 1,965,000 | 1,612,000 | 1,622,000 | 1,569,000 | 2,637,000 | 150,000 | 150,000 | 150,000 | 150,000 | 151,000 | 150,000 | 2,129,000 | 616,000 | 308,000 | 300,000 | 2,230,000 | 955,000 | 625,000 | 625,000 | 1,416,000 | 625,000 | 625,000 | 625,000 | 625,000 | 625,000 | 625,000 | ||||||||||||||||||||||
| short-term investments | 172,005,000 | 189,902,000 | 216,137,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| trade receivables | 91,177,000 | 93,394,000 | 79,069,000 | 72,456,000 | 68,759,000 | 60,586,000 | 56,950,000 | 53,646,000 | 57,667,000 | 48,639,000 | 50,599,000 | 42,610,000 | 41,491,000 | 36,415,000 | 29,413,000 | 26,212,000 | 27,620,000 | 18,386,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| inventory | 5,044,000 | 6,873,000 | 8,087,000 | 7,562,000 | 4,450,000 | 29,781,000 | 28,683,000 | 29,630,000 | 27,033,000 | 27,466,000 | 27,533,000 | 27,019,000 | 23,378,000 | 16,144,000 | 15,791,000 | 7,039,000 | 1,776,000 | 1,000,000 | 600,000 | 1,649,000 | 821,000 | 221,000 | 7,000 | 1,305,000 | 655,000 | 500,000 | 2,232,000 | 1,949,000 | 1,949,000 | 1,612,000 | 1,308,000 | 1,210,000 | 683,000 | 263,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses and other current assets | 12,541,000 | 14,327,000 | 13,752,000 | 16,281,000 | 16,426,000 | 18,381,000 | 19,542,000 | 20,016,000 | 14,112,000 | 15,157,000 | 12,586,000 | 11,070,000 | 11,053,000 | 12,333,000 | 9,986,000 | 8,975,000 | 5,560,000 | 5,908,000 | 5,528,000 | 5,241,000 | 3,016,000 | 5,249,000 | 4,422,000 | 3,447,000 | 2,341,000 | 2,087,000 | 2,390,000 | 2,445,000 | 1,729,000 | 2,397,000 | 1,381,000 | 1,421,000 | 1,524,000 | 1,721,000 | 1,438,000 | 2,007,000 | 1,674,000 | 3,221,000 | 4,870,000 | 4,970,000 | 5,449,000 | 4,322,000 | 6,172,000 | 4,546,000 | 5,020,000 | 835,000 | 1,725,000 | 1,656,000 | 1,179,000 | 1,781,000 | 1,097,000 | 826,000 | 344,000 | 407,000 | 378,000 | 795,000 | 260,000 | 676,000 | 1,004,430 | 1,187,000 | 1,421,000 | 1,275,000 | 1,055,712 | 3,201,000 | 6,744,000 | 692,000 | 1,136,842 | 2,331,000 | 2,369,000 | 3,131,000 | 1,879,463 | 2,101,000 | 2,287,000 | 1,865,000 | 3,775,975 | 1,705,000 | 4,504,000 | 2,727,000 | 839,662 | 644,000 | 739,000 | 671,000 | 699,284 | 571,000 | 541,000 |
| current assets held for sale | 29,170,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total current assets | 398,462,000 | 409,977,000 | 421,968,000 | 427,125,000 | 363,457,000 | 447,100,000 | 495,966,000 | 502,466,000 | 511,056,000 | 490,883,000 | 516,500,000 | 509,001,000 | 494,853,000 | 511,714,000 | 566,136,000 | 252,743,000 | 265,802,000 | 273,771,000 | 323,800,000 | 162,436,000 | 203,837,000 | 125,508,000 | 164,345,000 | 78,803,000 | 103,719,000 | 117,649,000 | 114,352,000 | 128,495,000 | 92,669,000 | 104,156,000 | 125,391,000 | 175,370,000 | 92,263,000 | 113,502,000 | 66,987,000 | 64,632,000 | 46,112,000 | 50,425,000 | 65,990,000 | 84,502,000 | 107,088,000 | 81,366,000 | 89,343,000 | 135,144,000 | 138,250,000 | 35,731,000 | 42,121,000 | 46,839,000 | 33,530,000 | 35,407,000 | 41,978,000 | 46,582,000 | 45,064,000 | 52,949,000 | 52,858,000 | 60,446,000 | 79,877,000 | 100,451,000 | 87,418,974 | 89,762,000 | 79,755,000 | 92,790,000 | 111,022,152 | 50,686,000 | 57,451,000 | 65,129,000 | 75,024,706 | 80,111,000 | 55,620,000 | 77,259,000 | 91,704,652 | 91,561,000 | 51,428,000 | 47,288,000 | 45,789,686 | 48,659,000 | 61,246,000 | 71,794,000 | 81,100,061 | 31,479,000 | 33,791,000 | 41,708,000 | 23,872,379 | 23,524,000 | 24,705,000 |
| long-term inventory | 22,205,000 | 25,097,000 | 23,187,000 | 21,633,000 | 24,525,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| property and equipment | 8,457,000 | 7,593,000 | 7,777,000 | 7,421,000 | 7,663,000 | 7,831,000 | 7,910,000 | 8,999,000 | 8,438,000 | 8,376,000 | 8,617,000 | 8,464,000 | 8,702,000 | 8,799,000 | 8,714,000 | 7,829,000 | 7,669,000 | 7,035,000 | 7,113,000 | 7,142,000 | 7,149,000 | 7,270,000 | 7,347,000 | 7,452,000 | 7,551,000 | 7,644,000 | 9,135,000 | 9,236,000 | 9,390,000 | 9,395,000 | 9,546,000 | 9,613,000 | 9,602,000 | 9,753,000 | 9,922,000 | 10,095,000 | 10,112,000 | 8,362,000 | 5,149,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| long-term investments | 10,101,000 | 20,548,000 | 20,323,000 | 19,426,000 | 64,317,000 | 3,445,000 | 3,432,000 | 18,077,000 | 34,332,000 | 6,829,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| right of use assets | 11,546,000 | 11,982,000 | 12,008,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other assets | 3,592,000 | 4,850,000 | 5,157,000 | 15,649,000 | 12,457,000 | 12,961,000 | 13,084,000 | 11,459,000 | 6,946,000 | 7,046,000 | 6,806,000 | 6,797,000 | 6,983,000 | 7,207,000 | 6,472,000 | 5,191,000 | 3,813,000 | 3,625,000 | 3,802,000 | 3,646,000 | 3,720,000 | 3,811,000 | 3,590,000 | 4,245,000 | 4,333,000 | 5,390,000 | 978,000 | 1,420,000 | 841,000 | 222,000 | 2,027,000 | 1,955,000 | 1,871,000 | 2,271,000 | 3,813,000 | 2,190,000 | 1,610,000 | 2,714,000 | 5,468,000 | 5,239,000 | 5,699,000 | 6,495,000 | 6,031,000 | 1,277,000 | 2,700,000 | 4,495,000 | 3,620,000 | 5,075,000 | 5,695,000 | 6,074,000 | 8,694,000 | 9,114,000 | 8,704,000 | 7,734,000 | 7,433,000 | 7,157,000 | 6,695,000 | 5,930,000 | |||||||||||||||||||||||||||
| non-current assets held for sale | 2,825,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total assets | 457,188,000 | 480,047,000 | 490,420,000 | 491,254,000 | 472,419,000 | 467,892,000 | 516,960,000 | 522,924,000 | 529,885,000 | 509,737,000 | 550,000,000 | 558,594,000 | 510,538,000 | 527,720,000 | 588,151,000 | 265,763,000 | 277,284,000 | 284,431,000 | 334,715,000 | 176,226,000 | 214,706,000 | 136,589,000 | 175,282,000 | 90,500,000 | 116,344,000 | 142,338,000 | 146,841,000 | 168,308,000 | 136,644,000 | 155,372,000 | 178,259,000 | 191,492,000 | 113,509,000 | 129,513,000 | 89,847,000 | 91,502,000 | 82,217,000 | 102,881,000 | 124,555,000 | 138,956,000 | 150,181,000 | 129,867,000 | 136,874,000 | 137,125,000 | 141,975,000 | 43,387,000 | 48,866,000 | 53,205,000 | 39,916,000 | 46,899,000 | 57,439,000 | 64,094,000 | 76,236,000 | 80,085,000 | 82,208,000 | 92,511,000 | 108,412,000 | 122,766,000 | 109,447,235 | 111,354,000 | 116,103,000 | 124,655,000 | 142,190,106 | 60,588,000 | 64,694,000 | 72,602,000 | 84,691,677 | 99,351,000 | 107,649,000 | 129,144,000 | 142,716,839 | 141,154,000 | 78,426,000 | 67,916,000 | 68,485,421 | 80,198,000 | 91,879,000 | 102,224,000 | 99,248,394 | 38,153,000 | 43,425,000 | 49,489,000 | 32,468,571 | 37,885,000 | 41,765,000 |
| liabilities and stockholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 8,589,000 | 10,049,000 | 11,644,000 | 13,482,000 | 7,786,000 | 11,910,000 | 20,893,000 | 10,567,000 | 13,889,000 | 6,254,000 | 14,356,000 | 8,622,000 | 12,024,000 | 13,881,000 | 27,808,000 | 19,693,000 | 10,087,000 | 13,529,000 | 18,713,000 | 11,616,000 | 9,354,000 | 10,061,000 | 13,988,000 | 10,084,000 | 8,298,000 | 6,935,000 | 7,769,000 | 7,911,000 | 4,122,000 | 3,588,000 | 6,337,000 | 4,603,000 | 1,844,000 | 5,433,000 | 4,269,000 | 2,760,000 | 5,051,000 | 7,691,000 | 9,307,000 | 3,782,000 | 3,822,000 | 5,307,000 | 2,849,000 | 2,266,000 | 2,360,000 | 1,352,000 | 4,174,000 | 1,241,000 | 989,000 | 1,073,000 | 3,974,000 | 2,293,000 | 3,328,000 | 2,062,000 | 2,497,000 | 3,583,000 | 5,012,000 | 6,254,000 | 8,200,822 | 3,261,000 | 1,438,000 | 6,352,000 | 18,069,767 | 3,200,000 | 2,793,000 | 4,185,000 | 5,265,947 | 3,239,000 | 9,317,000 | 14,763,000 | 19,771,375 | 16,383,000 | 10,578,000 | 8,209,000 | 5,886,967 | 7,974,000 | 5,206,000 | 6,867,000 | 8,812,985 | 2,231,000 | 1,208,000 | 1,672,000 | 1,970,443 | 2,024,000 | 849,000 |
| accrued expenses | 107,114,000 | 92,635,000 | 113,292,000 | 104,197,000 | 89,598,000 | 79,249,000 | 102,882,000 | 77,392,000 | 75,300,000 | 75,212,000 | 87,565,000 | 69,265,000 | 79,711,000 | 63,584,000 | 72,670,000 | 56,308,000 | 48,765,000 | 32,719,000 | 33,942,000 | 30,462,000 | 24,843,000 | 20,192,000 | 21,365,000 | 24,954,000 | 19,343,000 | 16,547,000 | 15,891,000 | 15,120,000 | 19,409,000 | 15,624,000 | 12,699,000 | 11,871,000 | 12,329,000 | 11,335,000 | 10,836,000 | 10,782,000 | 11,783,000 | 17,328,000 | 16,237,000 | 23,027,000 | 19,001,000 | 12,291,000 | 11,723,000 | 11,252,000 | 7,309,000 | 6,312,000 | 5,742,000 | 7,668,000 | 5,773,000 | 5,647,000 | 9,860,000 | 8,035,000 | 8,206,000 | 9,253,000 | 12,616,000 | 12,030,000 | 12,309,000 | 11,997,000 | 16,486,920 | 13,613,000 | 10,250,000 | 11,336,000 | 15,794,800 | 11,145,000 | 7,248,000 | 6,010,000 | 8,442,398 | 9,107,000 | 2,730,000 | 5,498,000 | 2,863,815 | 2,902,000 | 1,249,000 | 1,537,000 | 1,506,712 | 1,630,000 | 1,547,000 | 1,482,000 | 1,252,018 | 1,216,000 | 1,053,000 | 1,011,000 | 563,961 | 1,244,000 | 1,209,000 |
| operating lease liabilities | 392,000 | 1,071,000 | 937,000 | 1,049,000 | 1,026,000 | 1,098,000 | 1,058,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| finance lease liabilities | 1,616,000 | 1,795,000 | 1,835,000 | 1,839,000 | 1,681,000 | 1,642,000 | 1,590,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| royalty financing obligations | 35,741,000 | 34,305,000 | 32,676,000 | 33,000,000 | 28,974,000 | 26,022,000 | 23,565,000 | 535,186,000 | 526,121,000 | 514,411,000 | 501,655,000 | 489,781,000 | 477,666,000 | 464,225,000 | 449,375,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities held for sale | 23,708,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total current liabilities | 177,160,000 | 139,855,000 | 160,384,000 | 153,567,000 | 129,065,000 | 119,921,000 | 149,988,000 | 90,763,000 | 93,498,000 | 85,157,000 | 105,514,000 | 81,637,000 | 95,390,000 | 81,017,000 | 103,718,000 | 133,608,000 | 115,601,000 | 101,201,000 | 105,654,000 | 111,777,000 | 102,650,000 | 92,699,000 | 92,335,000 | 82,169,000 | 71,948,000 | 66,326,000 | 69,477,000 | 64,357,000 | 74,173,000 | 75,342,000 | 74,836,000 | 69,237,000 | 58,937,000 | 58,557,000 | 54,360,000 | 51,520,000 | 56,194,000 | 63,070,000 | 64,453,000 | 64,444,000 | 63,772,000 | 61,862,000 | 57,687,000 | 49,823,000 | 44,937,000 | 13,689,000 | 15,256,000 | 13,182,000 | 11,958,000 | 11,324,000 | 17,224,000 | 12,564,000 | 19,106,000 | 16,165,000 | 26,299,000 | 19,333,000 | 21,960,000 | 21,771,000 | 27,822,024 | 20,246,000 | 15,098,000 | 21,094,000 | 37,253,000 | 17,735,000 | 13,464,000 | 13,562,000 | 17,108,005 | 17,559,000 | 17,346,000 | 25,945,000 | 28,117,599 | 24,735,000 | 17,157,000 | 13,579,000 | 10,734,616 | 12,905,000 | 9,681,000 | 11,007,000 | 11,381,766 | 3,447,000 | 2,261,000 | 2,683,000 | 2,834,359 | 3,268,000 | 2,058,000 |
| secured term loan | 242,794,000 | 315,413,000 | 314,869,000 | 314,333,000 | 313,822,000 | 308,484,000 | 303,231,000 | 232,522,000 | 231,624,000 | 223,867,000 | 144,516,000 | 140,236,000 | 136,082,000 | 132,050,000 | 126,796,000 | 123,039,000 | 119,735,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| non-current liabilities held for sale | 454,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities | 878,782,000 | 931,974,000 | 966,354,000 | 959,817,000 | 3,747,000 | 2,561,000 | 2,983,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ deficit: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized - 5,000; no shares issued and outstanding at june 30, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 2,099,000 | 2,092,000 | 2,085,000 | 2,071,000 | 2,066,000 | 2,063,000 | 2,058,000 | 1,898,000 | 1,895,000 | 1,889,000 | 1,879,000 | 1,864,000 | 1,859,000 | 1,856,000 | 1,843,000 | 1,798,000 | 1,787,000 | 1,777,000 | 1,769,000 | 1,766,000 | 1,764,000 | 1,542,000 | 1,541,000 | 1,104,000 | 1,104,000 | 1,103,000 | 1,101,000 | 1,096,000 | 989,000 | 987,000 | 984,000 | 984,000 | 804,000 | 804,000 | 738,000 | 738,000 | 737,000 | 737,000 | 734,000 | 733,000 | 732,000 | 725,000 | 720,000 | 719,000 | 717,000 | 601,000 | 591,000 | 591,000 | 542,000 | 514,000 | 509,000 | 509,000 | 501,000 | 492,000 | 457,000 | 452,000 | 451,000 | 451,000 | 449,590 | 449,000 | 449,000 | 440,000 | 439,068 | 383,000 | 383,000 | 382,751 | 382,000 | 381,000 | 381,000 | 379,672 | 380,000 | 295,000 | 294,000 | 292,488 | 292,000 | 292,000 | 291,000 | 288,135 | 264,000 | 262,000 | 262,000 | 217,583 | |||
| additional paid-in capital | 1,339,584,000 | 1,314,857,000 | 1,291,100,000 | 1,270,318,000 | 1,250,983,000 | 1,237,537,000 | 1,222,236,000 | 1,205,744,000 | 1,191,981,000 | 1,177,192,000 | 1,158,118,000 | 1,138,654,000 | 1,125,453,000 | 1,115,443,000 | 1,098,498,000 | 1,040,769,000 | 1,022,975,000 | 1,010,779,000 | 1,002,408,000 | 994,811,000 | 991,574,000 | 880,319,000 | 877,300,000 | 795,589,000 | 790,076,000 | 784,278,000 | 780,400,000 | 776,724,000 | 720,587,000 | 718,037,000 | 714,869,000 | 711,965,000 | 620,453,000 | 618,009,000 | 566,913,000 | 564,791,000 | 562,634,000 | 560,762,000 | 558,113,000 | 556,095,000 | 553,610,000 | 546,698,000 | 542,943,000 | 538,959,000 | 536,864,000 | 426,520,000 | 420,988,000 | 420,097,000 | 399,684,000 | 393,738,000 | 391,611,000 | 390,783,000 | 386,966,000 | 382,181,000 | 367,829,000 | 365,868,000 | 364,593,000 | 363,235,000 | 361,520,258 | 360,153,000 | 358,604,000 | 350,325,000 | 348,571,914 | 300,989,000 | 298,106,000 | 296,626,000 | 295,207,583 | 293,831,000 | 292,132,000 | 290,750,000 | 288,683,369 | 287,330,000 | 220,321,000 | 217,979,000 | 216,310,578 | 215,107,000 | 213,920,000 | 212,674,000 | 210,014,946 | 178,844,000 | 177,659,000 | 177,653,000 | 154,880,528 | 154,575,000 | 154,369,000 |
| accumulated other comprehensive income | 1,646,000 | 1,132,000 | 921,000 | 2,293,000 | 557,000 | 771,000 | 1,337,000 | 800,000 | 690,000 | 585,000 | 26,000 | -98,000 | 15,000 | 186,000 | 177,000 | 114,000 | 87,000 | 182,000 | 3,000 | 9,000 | 3,000 | 14,000 | 39,000 | 60,000 | 41,000 | 22,000 | 46,000 | 48,000 | 10,000 | -130,000 | 2,000 | 3,000 | 2,000 | 4,000 | 2,000 | 6,000 | 15,000 | 27,000 | 40,000 | 40,000 | 49,000 | 40,000 | 50,000 | 92,000 | 82,000 | 105,710 | 119,000 | 63,000 | 77,000 | -25,783 | 40,000 | 40,000 | 68,000 | 103,507 | 133,000 | 252,000 | 726,000 | 378,057 | 152,000 | -4,000 | 26,000 | 32,463 | 54,000 | 9,000 | |||||||||||||||||||||
| accumulated deficit | -1,764,923,000 | -1,770,008,000 | -1,770,040,000 | -1,743,245,000 | -1,729,212,000 | -1,716,538,000 | -1,681,159,000 | -1,619,428,000 | -1,583,279,000 | -1,507,953,000 | -1,454,620,000 | -1,383,079,000 | -1,340,559,000 | -1,281,700,000 | -1,207,504,000 | -1,189,725,000 | -1,130,924,000 | -1,087,726,000 | -1,023,442,000 | -962,949,000 | -916,834,000 | -878,227,000 | -840,628,000 | -838,006,000 | -800,414,000 | -762,785,000 | -731,969,000 | -704,537,000 | -674,940,000 | -656,494,000 | -631,843,000 | -612,300,000 | -597,166,000 | -580,280,000 | -566,061,000 | -561,558,000 | -550,030,000 | -533,749,000 | -510,917,000 | -492,782,000 | -478,161,000 | -483,062,000 | -467,898,000 | -456,226,000 | -447,495,000 | -432,846,000 | -422,709,000 | -417,280,000 | -409,279,000 | -397,107,000 | -392,601,000 | -381,548,000 | -371,848,000 | -359,572,000 | -353,520,000 | -340,328,000 | -325,870,000 | -309,599,000 | -296,572,332 | -286,372,000 | -275,508,000 | -265,315,000 | -262,719,149 | -277,871,000 | -267,244,000 | -258,560,000 | -249,267,614 | -259,338,000 | -250,343,000 | -237,634,000 | -224,536,044 | -222,253,000 | -211,269,000 | -204,306,000 | -195,480,520 | -185,431,000 | -169,828,000 | -159,745,000 | -151,862,667 | -144,702,000 | -137,057,000 | -131,409,000 | -125,763,899 | -120,475,000 | -115,179,000 |
| total stockholders’ deficit | -421,594,000 | -451,927,000 | -475,934,000 | -468,563,000 | -475,606,000 | -476,167,000 | -455,528,000 | -410,986,000 | -388,713,000 | -328,287,000 | -294,597,000 | -242,659,000 | -213,232,000 | -164,215,000 | -106,986,000 | -5,723,000 | -9,047,000 | -2,840,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders’ deficit | 457,188,000 | 480,047,000 | 490,420,000 | 491,254,000 | 472,419,000 | 467,892,000 | 516,960,000 | 522,924,000 | 529,885,000 | 509,737,000 | 550,000,000 | 558,594,000 | 510,538,000 | 527,720,000 | 588,151,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized - 5,000; no shares issued and outstanding at march 31, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized - 5,000; no shares issued and outstanding at december 31, 2024 and 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| investments | 233,172,000 | 193,617,000 | 252,221,000 | 278,344,000 | 246,685,000 | 264,455,000 | 243,022,000 | 119,543,000 | 179,959,000 | 144,912,000 | 47,964,000 | 3,212,000 | 8,114,000 | 13,454,000 | 28,239,000 | 46,827,000 | 15,935,000 | 11,185,000 | 22,054,000 | 38,532,000 | 61,387,000 | 72,753,000 | 77,736,000 | 67,737,000 | 53,636,000 | 47,540,000 | 64,115,000 | 43,848,000 | 40,977,000 | 23,524,000 | 32,546,000 | 17,434,000 | 27,079,000 | 22,914,000 | 22,664,000 | 23,700,000 | 17,584,000 | 19,160,000 | 18,232,000 | 5,977,000 | 10,589,000 | 17,807,000 | 16,891,000 | 16,541,000 | 9,358,000 | 13,462,000 | 14,708,000 | 17,062,000 | 12,958,000 | 15,617,000 | 25,274,000 | ||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized - 5,000; no shares issued and outstanding at september 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized - 5,000; no shares issued and outstanding at june 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized - 5,000; no shares issued and outstanding at march 31, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 522,000 | 1,779,000 | 1,200,000 | 1,224,000 | 1,554,000 | 1,521,000 | 1,471,000 | 1,421,000 | 602,000 | 551,000 | 2,509,000 | 2,528,000 | 2,547,000 | 2,565,285 | 4,345,000 | 4,345,000 | 4,756,000 | 4,658,266 | 4,680,000 | 4,620,000 | 3,161,000 | 2,699,463 | 2,699,000 | 2,391,000 | 2,162,000 | 873,786 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized — 5,000; no shares outstanding at december 31, 2023 and 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| lease financing obligation | 2,282,000 | 2,530,000 | 2,491,000 | 2,369,000 | 2,196,000 | 2,134,000 | 2,081,000 | 1,819,000 | 1,452,000 | 981,000 | 1,001,000 | 1,179,000 | 925,000 | 1,096,000 | 1,301,000 | 1,377,000 | 47,000 | 66,000 | 78,000 | 76,000 | 75,000 | 73,000 | 2,704,000 | 2,704,000 | 2,704,000 | 2,675,000 | 2,589,000 | 2,506,000 | 2,375,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| secured term loans | 297,995,000 | 293,176,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized - 5,000; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; shares authorized — 5,000; no shares outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest payable | 25,553,000 | 25,217,000 | 23,547,000 | 21,670,000 | 19,304,000 | 17,806,000 | 16,381,000 | 14,904,000 | 13,423,000 | 14,745,000 | 13,392,000 | 11,848,000 | 10,427,000 | 14,832,000 | 13,465,000 | 12,095,000 | 10,705,000 | 11,587,000 | 10,291,000 | 8,990,000 | 7,563,000 | 9,203,000 | 7,974,000 | 6,746,000 | 5,517,000 | 4,450,000 | 7,241,000 | 6,029,000 | 4,824,000 | 3,786,000 | 4,552,000 | 3,867,000 | 2,734,000 | 3,658,000 | 3,068,000 | 1,998,000 | 928,000 | 3,500,000 | 2,450,000 | 1,400,000 | 350,000 | 1,318,000 | 257,000 | ||||||||||||||||||||||||||||||||||||||||||
| non-recourse notes payable | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 29,890,000 | 29,780,000 | 29,671,000 | 29,561,000 | 29,451,000 | 29,341,000 | 29,231,000 | 29,121,000 | 29,012,000 | 28,902,000 | 28,792,000 | 28,682,000 | 28,572,000 | 28,463,000 | 28,353,000 | 28,243,000 | 28,133,000 | 28,023,000 | 27,914,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | ||||||||||||||||||||||||||||||||||||||||||
| inventories | 13,663,000 | 9,846,000 | 5,113,000 | 6,241,000 | 5,233,000 | 263,000 | 263,000 | 263,000 | 898,000 | 898,000 | 898,000 | 898,076 | 898,000 | 907,000 | 844,000 | 6,281,263 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| royalty financing obligation | 142,114,000 | 136,862,000 | 131,296,000 | 124,717,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; shares authorized - 5,000; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ equity | -147,044,000 | -106,075,000 | -74,988,000 | 33,637,000 | 76,507,000 | 3,648,000 | 38,252,000 | -9,193,000 | 22,507,000 | 49,235,000 | 72,873,000 | 46,184,000 | 62,054,000 | 83,767,000 | 100,632,000 | 24,076,000 | 38,530,000 | 1,578,000 | 3,993,000 | 13,387,000 | 27,798,000 | 47,724,000 | 64,045,000 | 76,089,000 | 64,371,000 | 75,635,000 | 83,454,000 | 90,089,000 | 3,410,000 | 9,784,000 | 15,659,000 | 23,150,000 | 14,806,000 | 26,042,000 | 39,266,000 | 54,169,000 | 65,503,226 | 74,349,000 | 83,608,000 | 85,527,000 | 86,266,050 | 23,545,000 | 31,285,000 | 38,517,000 | 46,426,227 | 35,008,000 | 42,423,000 | 54,223,000 | 64,905,054 | 65,609,000 | 9,343,000 | 13,993,000 | 21,155,009 | 44,393,000 | 53,220,000 | 58,440,414 | 34,406,000 | 40,864,000 | 46,506,000 | 29,334,212 | 34,317,000 | 39,407,000 | |||||||||||||||||||||||
| total liabilities and stockholders’ equity | 265,763,000 | 277,284,000 | 284,431,000 | 334,715,000 | 176,226,000 | 214,706,000 | 136,589,000 | 175,282,000 | 90,500,000 | 116,344,000 | 142,338,000 | 146,841,000 | 168,308,000 | 136,644,000 | 155,372,000 | 178,259,000 | 191,492,000 | 113,509,000 | 129,513,000 | 89,847,000 | 91,502,000 | 82,217,000 | 102,881,000 | 124,555,000 | 138,956,000 | 150,181,000 | 129,867,000 | 136,874,000 | 137,125,000 | 141,975,000 | 43,387,000 | 48,866,000 | 53,205,000 | 39,916,000 | 46,899,000 | 57,439,000 | 64,094,000 | 76,236,000 | 80,085,000 | 82,208,000 | 92,511,000 | 108,412,000 | 122,766,000 | 109,447,235 | 111,354,000 | 116,103,000 | 124,655,000 | 142,190,106 | 60,588,000 | 64,694,000 | 72,602,000 | 84,691,677 | 99,351,000 | 107,649,000 | 129,144,000 | 142,716,839 | 141,154,000 | 78,426,000 | 67,916,000 | 68,485,421 | 91,879,000 | 102,224,000 | 99,248,394 | 38,153,000 | 43,425,000 | 49,489,000 | 32,468,571 | 37,885,000 | 41,765,000 | ||||||||||||||||
| deferred collaboration revenue | 405,000 | 150,000 | 432,000 | 715,000 | 1,067,000 | 2,120,000 | 221,000 | 221,000 | 221,000 | 221,000 | 200,000 | 300,000 | 7,300,000 | 8,484,000 | 8,686,000 | 1,717,000 | 1,869,000 | 2,022,000 | 2,282,000 | 2,134,000 | 2,163,000 | 2,163,000 | 2,102,000 | 6,453,000 | 1,490,000 | 1,481,000 | 1,481,000 | 1,482,000 | 1,473,000 | 1,473,000 | 1,539,000 | 1,538,000 | 1,536,000 | 1,392,000 | 1,308,000 | 4,072,000 | 2,400,000 | 9,786,000 | 3,370,000 | 3,321,000 | 2,497,000 | 2,496,534 | 2,497,000 | 2,497,000 | 2,497,000 | 2,496,534 | |||||||||||||||||||||||||||||||||||||||
| receivables | 8,646,000 | 3,238,000 | 897,000 | 3,280,000 | 2,115,000 | 2,369,000 | 1,024,000 | 4,325,000 | 4,562,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| senior credit facility | 19,148,000 | 19,056,000 | 14,026,000 | 9,020,000 | 4,036,000 | 4,580,000 | 1,621,000 | 6,530,000 | 6,497,000 | 6,464,000 | 4,727,000 | 2,997,000 | 1,276,000 | 22,777,000 | 22,665,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ (deficit) equity | -19,262,000 | -41,253,000 | -1,126,000 | -454,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| receivables from collaborations | 5,422,000 | 3,997,000 | 5,642,000 | 22,146,000 | 3,598,000 | 3,602,000 | 5,002,000 | 4,293,000 | 3,394,000 | 2,342,000 | 5,694,000 | 6,117,000 | 8,985,000 | 3,325,000 | 9,564,000 | 8,768,000 | 5,968,000 | 2,234,000 | 7,384,000 | 6,243,000 | 7,495,000 | 4,296,000 | 5,594,000 | 3,849,000 | 3,768,000 | 5,084,000 | 5,852,000 | 5,831,000 | 11,634,000 | 15,961,000 | 26,062,000 | 30,227,210 | 25,564,000 | 20,531,000 | 26,627,000 | 33,722,207 | 11,626,000 | 8,075,000 | 9,847,000 | 11,982,430 | 13,102,000 | 14,850,000 | 28,579,000 | 39,127,676 | 4,556,145 | ||||||||||||||||||||||||||||||||||||||||
| deferred rent | 54,000 | 81,000 | 107,000 | 131,000 | 155,000 | 178,000 | 201,000 | 223,000 | 244,000 | 265,000 | 297,000 | 313,000 | 329,000 | 345,000 | 361,000 | 378,000 | 138,000 | 151,000 | 52,000 | 52,537 | 52,000 | 52,000 | 52,000 | 52,537 | 53,000 | 53,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; shares authorized — 5,000; no shares outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other non-current liabilities | 3,543,000 | 3,742,000 | 3,889,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; shares authorized — 5,000; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred collaboration expense | 9,000 | 9,000 | 8,000 | 12,000 | 152,000 | 210,000 | 218,000 | 79,000 | 82,000 | 85,000 | 98,000 | 89,000 | 90,000 | 90,000 | 88,000 | 101,000 | 76,000 | 76,000 | 76,000 | 75,000 | 75,000 | 75,000 | 73,000 | 73,000 | 418,000 | 412,000 | 404,000 | 519,000 | 452,000 | 2,301,000 | 753,000 | 751,000 | 719,000 | 718,719 | 719,000 | 719,000 | 374,000 | 374,221 | 374,000 | 376,000 | 376,000 | 376,972 | 10,719,000 | 10,951,000 | 11,182,000 | 11,407,120 | 11,640,000 | 11,872,000 | 11,470,000 | 10,597,750 | 10,787,000 | 7,824,000 | 7,900,000 | 5,825,243 | |||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -89,000 | -297,000 | -410,000 | -452,000 | -476,000 | -243,000 | -17,000 | -15,000 | -3,000 | -12,000 | -206,000 | -1,000 | -92,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| foreign currency derivative | 1,904,000 | 974,000 | 2,805,000 | 981,000 | 1,581,000 | 1,678,000 | 2,791,000 | 4,749,000 | 5,531,000 | 4,959,000 | 3,962,000 | 4,000,000 | 2,926,000 | 2,340,000 | 1,342,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| receivables from product sales | 5,641,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred product sales revenue | 16,000 | 46,000 | 5,533,000 | 5,605,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| furniture and equipment | 1,146,000 | 1,047,000 | 727,000 | 207,000 | 210,000 | 216,000 | 260,000 | 306,000 | 359,000 | 425,000 | 486,000 | 583,000 | 751,000 | 882,000 | 999,000 | 1,098,000 | 1,353,000 | 1,537,000 | 1,734,000 | 1,929,049 | 3,087,000 | 3,330,000 | 3,564,000 | 3,871,653 | 4,175,000 | 4,429,000 | 4,566,000 | 4,880,475 | 5,271,000 | 5,232,000 | 5,086,000 | 5,294,079 | 4,120,000 | 3,169,000 | 3,062,000 | 3,029,271 | 2,679,000 | 2,671,000 | 2,760,000 | 2,407,954 | 2,342,000 | 2,456,000 | 2,634,000 | 2,817,154 | 2,948,000 | 3,163,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; shares authorized— 5,000; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest reserve | 1,742,000 | 1,742,000 | 1,742,000 | 1,742,000 | 3,000,000 | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| marketable securities | 21,558,000 | 40,583,000 | 37,129,000 | 40,323,169 | 49,595,000 | 41,531,000 | 43,169,000 | 27,838,812 | 17,259,000 | 28,446,000 | 37,909,000 | 39,186,404 | 48,726,000 | 13,260,000 | 17,674,000 | 19,542,193 | 24,620,000 | 23,690,000 | 27,849,000 | 33,040,038 | 36,082,000 | 29,712,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: 5,000 shares authorized; none issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accrued vacation | 714,000 | 585,211 | 823,000 | 861,000 | 857,000 | 839,362 | 828,000 | 842,000 | 780,000 | 794,375 | 828,000 | 914,000 | 888,000 | 824,143 | 770,000 | 710,000 | 672,000 | 641,474 | 602,000 | 537,000 | 496,000 | 442,977 | 299,955 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized — 5,000 series b junior participating preferred stock, .001 par value; shares authorized — 95; shares issued and outstanding — none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized — 5,000,000 series b junior participating preferred stock, .001 par value; shares authorized — 95,000; shares issued and outstanding — none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized – 5,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series b junior participating preferred stock, .001 par value; shares authorized – 45; shares issued and outstanding – none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95,000; shares issued and outstanding – 38,735 in 2009 and 38,275 in 2008 | 387,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized — 5,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series b junior participating preferred stock, .001 par value; shares authorized — 45; shares issued and outstanding — none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized – 5,000 series b junior participating preferred stock, .001 par value; shares authorized – 45; shares issued and outstanding – none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized — 5,000,000 series b junior participating preferred stock, .001 par value; shares authorized — 45,000; shares issued and outstanding — none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized - 5,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series b junior participating preferred stock, .001 par value; shares authorized - 45; shares issued and outstanding - none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patents and licenses, net of accumulated amortization of 32,094 in 2006 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized - 5,000,000 series b junior participating preferred stock, .001 par value; shares authorized - 45,000; shares issued and outstanding - none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| receivables from collaborations – billed | 5,005,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| receivables from collaborations – unbilled | 15,743,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patents and licenses | 297,000 | 314,000 | 303,000 | 260,000 | 248,000 | 222,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| receivables from collaborations — billed | 3,460,000 | 3,871,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| receivables from collaborations — unbilled | 14,813,000 | 4,496,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized — 5,000 series b junior participating preferred stock, .001 par value; shares authorized — 45; shares issued and outstanding — none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patents and licenses, net of accumulated amortization of 32,094 in 2006 and 13,076 in 2005 | 290,694 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized - 5,000,000 series b junior participating preferred stock, .001 par value; shares authorized - 45,000; shares issued and outstanding — none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| receivable from collaboration | 3,139,000 | 1,975,000 | 630,000 | 30,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, .01 par value; shares authorized – 1,800; shares issued and outstanding – none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders' equity | 30,022,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders' equity | 80,198,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series b junior participating preferred stock, .001 par value; shares authorized – 21.5; shares issued and outstanding – none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| securities held-to-maturity | 25,422,000 | 21,103,572 | 21,738,000 | 23,812,000 | 18,988,000 | 14,334,631 | 9,144,000 | 7,118,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patents and licenses, net of accumulated amortization of 13,076 in 2005 and 3,934 in 2004 | 187,635 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock: shares authorized - 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, .01 par value; shares authorized - 1,800,000; shares issued and outstanding - none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series b junior participating preferred stock, .001 par value; shares authorized - 45,000; shares issued and outstanding - none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patents | 284,000 | 268,000 | 258,000 | 242,000 | 195,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series b junior participating preferred stock, .001 par value; shares authorized – 21.5; shares issued and outstanding - none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patents and licenses, less accumulated amortization of 3,934 in 2004 and 955 in 2003 | 248,586 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series b junior participating preferred stock, .001 par value; shares authorized - 21,500; shares issued and outstanding - none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, .01 par value; shares | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized - 1,800; shares issued and outstanding - none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| series b junior participating preferred stock, .001 par value; shares | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized - 21.5; shares issued and outstanding - none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45,000; shares issued and outstanding - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21,682 in 2004 and 17,871 in 2003 | 217,000 |
We provide you with 20 years of balance sheets for BioCryst Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BioCryst Pharmaceuticals. Explore the full financial landscape of BioCryst Pharmaceuticals stock with our expertly curated balance sheets.
The information provided in this report about BioCryst Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.